48,830
edits
Difference between revisions of "Sarcina"
Jump to navigation
Jump to search
→Microscopic: +SO
(→Microscopic: +SO) |
|||
| Line 44: | Line 44: | ||
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193598/figure/F2/ Sarcina (nih.gov)]. | *[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193598/figure/F2/ Sarcina (nih.gov)]. | ||
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627895/figure/F2/ Sarcina (nih.gov)].<ref name=pmid23599657/> | *[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627895/figure/F2/ Sarcina (nih.gov)].<ref name=pmid23599657/> | ||
==Sign out== | |||
===Urine cytology=== | |||
<pre> | |||
Abundant micro-organisms compatible with Sarcina, see comment. | |||
Acute inflammation. | |||
NEGATIVE for High-Grade Urothelial Carcinoma. | |||
Comment: | |||
The micro-organisms are arranged in distinctive tetrads, as is typical for Sarcina. | |||
This is an uncommon finding.[1] Treatment should be considered within the clinical context. | |||
1. Bommannan K, Gaspar BL, Sachdeva MUS. BMJ Case Rep. 2016 Oct 13;2016:bcr2016216991. doi:10.1136/bcr-2016-216991 | |||
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073697/pdf/bcr-2016-216991.pdf | |||
</pre> | |||
==See also== | ==See also== | ||